BostonSight Announces International Partnership

Source: BostonSight

Tuesday, October 03, 2017 | Cataract Surgery , Partnerships


BostonSight and the LV Prasad Eye Institute (LVPEI), a non-profit, non-government eye care institution located in Hyderabad, India, announced a global partnership to manufacture and distribute BostonSight scleral contact lenses. 

LVPEI will manufacture and distribute BostonSight scleral lenses to ophthalmologists and optometrists to prescribe to their patients in India, South East Asia, the Middle East and Africa. This is the first time that BostonSight PROSE (prosthetic replacement of the ocular surface ecosystem), and BostonSight SCLERAL lenses will be fabricated outside of the United States. Both organizations serve and subsidize under-privileged populations who benefit from access to this unique treatment solution that oftentimes is the only vision impairment alleviation for a variety of ocular surface disorders.

The World Health Organization estimates a Global visual impairment population in excess of 450 million people. Those who suffer from mild, moderate and severe visual impairment experience significant reduction in quality of life, and the ability to lead productive lifestyles.

BostonSight CEO, Gene Guselli, and LVPEI Founder and Chairman, Dr. Gullapalli N. Rao, jointly announced the Partnership at the International Association of Contact Lens Educators (IACLE) 2017 Congress and the World Congress of Optometry in Hyderabad, India in mid-September. 

"This partnership creates an opportunity for us to combine our collective expertise and provide affordable access to visually impaired, underserved populations around the world.  We are privileged to work with LV Prasad to make this a reality," Mr. Guselli said in a company news release.

This expanded relationship with LVPEI brings our treatment solutions to millions of patients throughout the world, and furthers BostonSight's mission "to improve the quality of life for patients and their families by transforming the understanding, treatment and care of the ocular surface," Mr. Guselli said.


Comments

You must be logged in to leave a comment.